Valuation: Danaher Corporation

Market Cap 163B 148B 136B 123B 233B 15,355B 240B 1,636B 650B 8,209B 613B 600B 26,128B P/E 2026 *
36.9x
P/E 2027 * 30.9x
Enterprise Value 184B 166B 154B 139B 262B 17,289B 270B 1,843B 732B 9,243B 690B 676B 29,420B EV / Sales 2026 *
7x
EV / Sales 2027 * 6.34x
Free-Float
70.56%
Yield 2026 *
0.62%
Yield 2027 * 0.68%
1 day-0.36%
1 week+0.43%
Current month-0.43%
1 month+3.77%
3 months+13.41%
6 months+39.30%
Current year+1.01%
1 week 228.37
Extreme 228.37
237.95
1 month 217.55
Extreme 217.55
238.46
Current year 160.93
Extreme 160.93
242.8
1 year 160.93
Extreme 160.93
242.8
3 years 160.93
Extreme 160.93
281.7
5 years 160.93
Extreme 160.93
331.68
10 years 76.27
Extreme 76.27
333.96
Manager TitleAgeSince
Chief Executive Officer - 01/10/2026
Director of Finance/CFO - 28/02/2026
Chief Tech/Sci/R&D Officer - 25/08/2025
Director TitleAgeSince
Director/Board Member 74 01/07/1999
Chairman 74 01/01/1984
Director/Board Member 69 01/01/1984
Date Insider Type Main position Quantity % Market Cap. Importance
30/10/26 Free

Director

13 0.0000%
30/10/26 Free

Director

193 0.0000%
30/10/26 Free

Director

144 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-0.37%+0.43%+4.53%+17.99% 163B
-0.56%+0.19%+19.99%+56.37% 259B
+1.43%-1.51%-21.14%+57.88% 152B
+0.16%+3.63%-57.80%-17.52% 64.07B
+1.36%+5.26%+24.86%+66.43% 60.84B
+0.58%-1.32%+1.73%-7.06% 53.91B
-0.44%-1.73%+16.91%+59.81% 48.78B
-0.68%-0.91%+3.18%+81.04% 48.96B
-0.63%+0.14%+20.81%+82.58% 45.43B
+0.74%+0.10%+11.48%+17.78% 37B
Average +0.14%+0.06%+2.46%+41.53% 93B
Weighted average by Cap. +0.08%+0.49%+3.16%+43.05%

Financials

2026 *2027 *
Net sales 26.26B 23.75B 21.92B 19.84B 37.44B 2,469B 38.56B 263B 105B 1,320B 98.56B 96.46B 4,201B 28.28B 25.58B 23.61B 21.37B 40.32B 2,659B 41.53B 283B 113B 1,421B 106B 104B 4,524B
Net income 4.4B 3.98B 3.67B 3.32B 6.27B 413B 6.46B 44.05B 17.5B 221B 16.5B 16.15B 703B 5.22B 4.72B 4.35B 3.94B 7.44B 490B 7.66B 52.25B 20.76B 262B 19.57B 19.16B 834B
Net Debt 20.58B 18.61B 17.18B 15.55B 29.34B 1,935B 30.22B 206B 81.93B 1,034B 77.23B 75.59B 3,292B 16.09B 14.55B 13.43B 12.15B 22.93B 1,512B 23.62B 161B 64.04B 808B 60.37B 59.08B 2,573B
Projected Income Statement - Annual - Danaher Corporation
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).
Employees
59,000
Date Price Change Volume
14/11/26 USD 231.19 -0.42% 544,188
12/11/26 USD 232.16 -1.34% 2,382,361
11/11/26 USD 235.31 -0.34% 3,228,140
10/11/26 USD 236.11 +0.42% 3,396,149
09/11/26 USD 235.12 +2.12% 3,630,575
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Danaher Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
232.16USD
Average target price
259.90USD
Spread / Average Target
+11.95%